AVSTAT

This brand name is authorized in Nigeria.

Active ingredients

The drug AVSTAT contains one active pharmaceutical ingredient (API):

1
UNII 48A5M73Z4Q - ATORVASTATIN CALCIUM TRIHYDRATE
 

Atorvastatin is a selective, competitive inhibitor of HMG-CoA reductase. Atorvastatin lowers plasma cholesterol and lipoprotein serum concentrations by inhibiting HMG-CoA reductase and subsequently cholesterol biosynthesis in the liver and increases the number of hepatic LDL receptors on the cell surface for enhanced uptake and catabolism of LDL.

 
Read more about Atorvastatin

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-0271 Tablet Avstat 10 Tablets TAB 10 mg Tablet 28/10/2021
B4-1261 Tablet Avstat 20 mg Tablets TAB 20 mg 3 x 10's (in Alu-Alu blisters) Tablet White to off white, round, biconvex, film coated tablet, deboss with "AT20" on one side and plain on the side of each tablet 3 RNW-PP-260177 AVSTAT 20MG TABLETS ATORVASTATIN 20MG Atorvastatin Calcium Trihydrate BP Eq. to Atorvastatin………….20 mg Excipient …………………… q.s. Microcrystalline cellulose Lactose DC Maize starch Croscarmellose Sodium Purified Talc Magnesium Stearate HPMC E 15 Diethyl Phthalate Titanium Dioxide Isopropyl Alcohol Methylene Chloride B4-1261 Drugs Imported Products 3X10 Prescription Only Medicine (POM) 4/7/2022 FIDSON HEALTHCARE PLC, IKORODU ROAD, OBANIKORO LAGOS LAGOS 8023067964 nmakaokolo@yahoo.com V.S INTERNATIONAL PVT. LTD., PLOT NO 17 & 18 GOLDEN INDUSTRIAL ESTATE, SOMNATH ROAD, DABHEL, India 06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C10AA05 Atorvastatin C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AA HMG CoA reductase inhibitors
Discover more medicines within C10AA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-0271, B4-1261

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈